[Tissue plasminogen activator and intravitreal gas for the treatment of Terson's syndrome: case report]. / Ativador do plasminogênio tecidual e gás intravítreo no tratamento da síndrome de Terson: relato de caso.

The case of a 35 year-old male patient is reported. The patient had a clinical history of craniocerebral trauma and premacular hemorrhage of Terson syndrome in the left eye. After waiting for 45 days, without hemorrhage resolution, the patient received an intravitreal injection of sulfur hexafluoride gas and tPA; an almost complete hemorrhage absorption occurred after a week as well as a considerable improvement of visual acuity. In the report, relevant aspects of Terson syndrome and of intravitreal injection of gas and tPA are also described through a literature review.

Ativador do plasminogênio tecidual e gás intravítreo no tratamento da síndrome de Terson: relato de caso: [revisão] / Tissue plasminogen activator and intravitreal gas for the treatment of Terson's syndrome: case report: [review]

Relata-se o caso de um paciente de 35 anos de idade, sexo masculino, com história de trauma cranioencefálico, que evoluiu com hemorragia pré-macular da síndrome de Terson no olho esquerdo. Após 45 dias de conduta expectante, sem resolução da hemorragia, foi realizada injeção intravítrea de gás hexafluoreto de enxofre e tPA, evoluindo com absorção quase completa da hemorragia após uma semana e considerável melhora da acuidade visual. Descreve-se também aspectos importantes da síndrome de Terson e da injeção intravítrea de gás e tPA por meio de revisão da literatura.

The case of a 35 year-old male patient is reported. The patient had a clinical history of craniocerebral trauma and premacular hemorrhage of Terson syndrome in the left eye. After waiting for 45 days, without hemorrhage resolution, the patient received an intravitreal injection of sulfur hexafluoride gas and tPA; an almost complete hemorrhage absorption occurred after a week as well as a considerable improvement of visual acuity. In the report, relevant aspects of Terson syndrome and of intravitreal injection of gas and tPA are also described through a literature review.

[Uveal effusion associated with presumed tuberculosis: case report]. / Efusão uveal associada à tuberculose presumida: relato de caso.

The authors report a rare association of uveal effusion with presumed ocular tuberculosis in a male patient who presented clinical improvement with the systemic use of prednisone 40 mg/d and rifampicin 600 mg/d. In addition, relevant aspects of the uveal effusion such as the pathogenesis, evolution of the disease, differential diagnosis and treatment are described through a revision of the literature.

Efusão uveal associada à tuberculose presumida: relato de caso / Uveal effusion associated with presumed tuberculosis: case report

Os autores relatam a rara associação de efusão uveal e tuberculose ocular presumida em paciente do sexo masculino que apresentou melhora clínica com o uso sistêmico de prednisona 40 mg/d e rifampicina 600 mg/d. Descrevem, ainda, aspectos relevantes da efusão uveal, como etiopatogenia, evolução da doença, diagnóstico diferencial e tratamento, por meio de revisão da literatura.

The authors report a rare association of uveal effusion with presumed ocular tuberculosis in a male patient who presented clinical improvement with the systemic use of prednisone 40 mg/d and rifampicin 600 mg/d. In addition, relevant aspects of the uveal effusion such as the pathogenesis, evolution of the disease, differential diagnosis and treatment are described through a revision of the literature.